Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
November 18 - 21, 2004
Following the success of the first Joint Cold Spring Harbor/Wellcome Trust Conference conference on Pharmacogenomics held in late September 2003 at the Wellcome Trust Genome Campus in Hinxton, UK, we are pleased to announce a second conference in this series, to be held at Cold Spring Harbor Laboratory, beginning on Thursday November 18, 2004 and running through lunch on Sunday November 21.This meeting will focus on the opportunities presented by the growing contribution of emerging genomic information and technologies to interdisciplinary approaches in the study of variable responses of humans to drugs and toxic agents, and how research may benefit the individual. The meeting will provide an in depth focus on diverse areas including the biochemistry and physiology of drug action, uptake and metabolism, and how this is affected by genetics; the opportunities for discovery and design of new therapeutic agents; personalizing medicine; understanding and managing adverse drug reactions; the impact of academic and commercial initiatives; ethical, legal, regulatory and social consequences of genetics applied to medicines. Topics: • Genes & Sequence Variants
• Genotype & Phenotype Correlations
• Molecular Mechanisms of Drug Action & Response
• Adverse Drug Reactions
• Drug Development & Use
• Pharmacogenomics & Disease: Psychiatric Diseases; Cancer;
Respiratory Diseases & Asthma; Metabolic & Cardiovascular Diseases;
Pediatric Diseases; Infectious Diseases
• Commercial, Economic & ELSI Implications
• Informatics & Software
|
|
|
Invited Speakers:
|
|
We aim to bring together senior and junior investigators, postdoctoral and postgraduate researchers, medical, regulatory and ethical experts in a range of disciplines to share existing research and experience, and to explore the potential of working together in new international and interdisciplinary research areas for the benefit of individual patients. Abstracts should contain new and unpublished material. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our website as soon as decisions have been made by the organizers. Please bring this notice to the attention of any of your colleagues who may be interested.
|
|